Companies › REGN
REGENERON PHARMACEUTICAL (REGN)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0000872589 · EDGAR filings · Updated 2026-07-07
REGENERON PHARMACEUTICAL (REGN) has reported institutional ownership of 84.4%, with 1,384 institutional managers holding positions valued at $67.7B per the latest 13F reporting period.
Latest updates
- 2026-07-07 — Insider transaction reported (Form 4)
- 2026-07-06 — Current report (8-K) filed
- 2026-07-02 — Notice of proposed sale filed (Form 144)
- 2026-06-17 — Current report (8-K) filed
- 2026-05-08 — Institutional holdings report (13F) filed
- 2026-05-04 — Insider transaction reported (Form 4)
- 2026-04-30 — SCHEDULE 13G filed
- 2026-04-29 — Quarterly report (10-Q) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, REGENERON PHARMACEUTICAL has 1,384 institutional holders and institutional ownership of 84.4%.
| # | Institution | Reported value | % of tracked total |
|---|---|---|---|
| 1 | BlackRock, Inc. | $6.91B | 10.2% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | $5.14B | 7.6% |
| 3 | STATE STREET CORP | $3.60B | 5.3% |
| 4 | Dodge & Cox | $3.44B | 5.1% |
| 5 | JPMORGAN CHASE & CO | $3.23B | 4.8% |
| 6 | FRANKLIN RESOURCES INC | $2.10B | 3.1% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | $2.01B | 3.0% |
| 8 | PRICE T ROWE ASSOCIATES INC /MD/ | $1.68B | 2.5% |
| 9 | Nuveen, LLC | $1.60B | 2.4% |
| 10 | LOOMIS SAYLES & CO L P | $1.48B | 2.2% |
Full holder history and quarter-over-quarter changes are available inside the app.
Insider activity
Insiders reported 104 transactions (0 buys, 57 sells) across 19 reporting insiders, with a net reported value of −$9.32M.
Related companies
BRISTOL-MYERS SQUIBB CO (BMY) · MEDTRONIC PLC (MDT) · BOSTON SCIENTIFIC CORP (BSX) · HCA HEALTHCARE INC (HCA) · 3M CO (MMM) · ZOETIS INC (ZTS)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-07.